Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Pharmaceuticals

    Pharmaceuticals - Page 6

    Cyient gets nod to manufacture assemblies for COVID-19 diagnosis units, X-ray system

    Cyient gets nod to manufacture assemblies for COVID-19 diagnosis units, X-ray system

    Medical Dialogues Bureau3 April 2020 8:52 AM
    Cyient’s facility in Mysore is dedicated to electronic manufacturing processes, including printed circuit board assemblies, cable harnesses, and...
    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    Medical Dialogues Bureau3 April 2020 8:47 AM
    New Delhi: Genetic diagnostics firm MedGenome has said it has raised USD 55 million (over Rs 415 crore) in funding led by LeapFrog...
    Takeda appoints Koki Sato as new country head for India

    Takeda appoints Koki Sato as new country head for India

    Medical Dialogues Bureau3 April 2020 8:35 AM
    New Delhi: Takeda India has announced the appointment of Koki Sato as the Country Head for the Company's India business. In his current capacity,...
    Zydus gets USFDA nod for Lamotrigine Extended-Release Tablets for seizures

    Zydus gets USFDA nod for Lamotrigine Extended-Release Tablets for seizures

    Medical Dialogues Bureau3 April 2020 8:02 AM
    Ahmedabad: Zydus Cadila has received final approval from the USFDA to market Lamotrigine Extended-Release Tablets USP in the strengths of 25 mg, 50...
    J&K sets up PMRU of NPPA to fight coronavirus

    J&K sets up PMRU of NPPA to fight coronavirus

    Medical Dialogues Bureau3 April 2020 6:15 AM
    Delhi: Jammu & Kashmir Union Territory has become 12th State where the Price Monitoring & Resource Unit (PMRU) has been set up by the National...
    Intas Contributes two million tablets of hydroxychloroquine for  Global Trials Against COVID-19

    Intas Contributes two million tablets of hydroxychloroquine for Global Trials Against COVID-19

    Medical Dialogues Bureau3 April 2020 4:45 AM
    Intas will provide up to two million tablets of hydroxychloroquine to the trial, free of charge, along with two million tablets of matched placebo.
    Aurobindo, Sandoz call off 900 million US dollar deal

    Aurobindo, Sandoz call off 900 million US dollar deal

    Medical Dialogues Bureau2 April 2020 9:57 AM
    New Delhi: Aurobindo Pharma on Thursday said the USD 900 million deal to acquire Sandoz Inc''s US-based generic oral solids and dermatology...
    Jubilant gets USFDA EIR for its Solid Dosage facility at Salisbury, Maryland USA

    Jubilant gets USFDA EIR for its Solid Dosage facility at Salisbury, Maryland USA

    Medical Dialogues Bureau2 April 2020 8:48 AM
    Noida: Jubilant Life Sciences Limited, an integrated global Pharmaceutical and Life Sciences Company, has announced that Jubilant Pharma Limited, a...
    Mylab collaborates with Serum India CEO Adar  Poonawalla, Abhijit Pawar to scale-up production  of COVID-19 test kits

    Mylab collaborates with Serum India CEO Adar Poonawalla, Abhijit Pawar to scale-up production of COVID-19 test kits

    Medical Dialogues Bureau2 April 2020 8:00 AM
    Pune: In order to scale up the operations and escalate faster delivery of testing kits for the novel coronavirus (COVID-19), Pune-based molecular...
    Coronavirus: Zydus Wellness launches hand sanitizer under Nycil brand to meet growing demand

    Coronavirus: Zydus Wellness launches hand sanitizer under Nycil brand to meet growing demand

    Medical Dialogues Bureau2 April 2020 7:30 AM
    Nycil sanitizer consists of neem and aloevera extracts that helps kill 99.9 percent germs, Zydus Wellness said
    COVID-19: US asks India to lift restrictions on export of pharmaceutical ingredients

    COVID-19: US asks India to lift restrictions on export of pharmaceutical ingredients

    Medical Dialogues Bureau2 April 2020 3:30 AM
    Washington: The United States officials are reportedly in contact with India asking the country to lift restrictions to give the US access to...
    Biocon gets USFDA EIR with VAI Classification for its Malaysian Insulin Manufacturing Facility

    Biocon gets USFDA EIR with VAI Classification for its Malaysian Insulin Manufacturing Facility

    Medical Dialogues Bureau1 April 2020 7:14 AM
    Bengaluru: Biocon Sdn Bhd, a subsidiary of Biocon Limited has announced that it has received the Establishment Inspection Report (EIR) from the U.S....
    PrevNext

    Popular Stories

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Lasa Supergenerics gets FDA nod for Progesterone

    Lasa Supergenerics gets FDA nod for Progesterone

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    Lupin Contributes Rs 21 crores in battle against COVID-19

    Lupin Contributes Rs 21 crores in battle against COVID-19

    Transasia-Erba group unveils TB testing device MX 16

    Transasia-Erba group unveils TB testing device MX 16

    Jubilant Life Sciences Karnataka plant shut on coronavirus scare

    Jubilant Life Sciences Karnataka plant shut on coronavirus scare

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok